Results
|
2141.
|
|
|
2142.
|
The PARP inhibitor Olaparib disrupts base excision repair of 5-aza-2'-deoxycytidine lesions. [electronic resource] by
- Orta, Manuel Luis
- Höglund, Andreas
- Calderón-Montaño, José Manuel
- Domínguez, Inmaculada
- Burgos-Morón, Estefanía
- Visnes, Torkild
- Pastor, Nuria
- Ström, Cecilia
- López-lázaro, Miguel
- Helleday, Thomas
Producer: 20141104
In:
Nucleic acids research vol. 42
Availability: No items available.
|
|
2143.
|
Targeted radiosensitization of ETS fusion-positive prostate cancer through PARP1 inhibition. [electronic resource] by
- Han, Sumin
- Brenner, J Chad
- Sabolch, Aaron
- Jackson, Will
- Speers, Corey
- Wilder-Romans, Kari
- Knudsen, Karen E
- Lawrence, Theodore S
- Chinnaiyan, Arul M
- Feng, Felix Y
Producer: 20140902
In:
Neoplasia (New York, N.Y.) vol. 15
Availability: No items available.
|
|
2144.
|
|
|
2145.
|
|
|
2146.
|
Pharmacologic characterization of fluzoparib, a novel poly(ADP-ribose) polymerase inhibitor undergoing clinical trials. [electronic resource] by
- Wang, Lei
- Yang, Changyong
- Xie, Chengying
- Jiang, Jiahua
- Gao, Mingzhao
- Fu, Li
- Li, Yun
- Bao, Xubin
- Fu, Haoyu
- Lou, Liguang
Producer: 20190308
In:
Cancer science vol. 110
Availability: No items available.
|
|
2147.
|
|
|
2148.
|
|
|
2149.
|
|
|
2150.
|
Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trials. [electronic resource] by
- Giatromanolaki, A
- Koukourakis, M I
- Sivridis, E
- Gatter, K C
- Trarbach, T
- Folprecht, G
- Shi, M M
- Lebwohl, D
- Jalava, T
- Laurent, D
- Meinhardt, G
- Harris, A L
Producer: 20130307
In:
British journal of cancer vol. 107
Availability: No items available.
|
|
2151.
|
|
|
2152.
|
|
|
2153.
|
Stereospecific PARP trapping by BMN 673 and comparison with olaparib and rucaparib. [electronic resource] by
- Murai, Junko
- Huang, Shar-Yin N
- Renaud, Amèlie
- Zhang, Yiping
- Ji, Jiuping
- Takeda, Shunichi
- Morris, Joel
- Teicher, Beverly
- Doroshow, James H
- Pommier, Yves
Producer: 20150219
In:
Molecular cancer therapeutics vol. 13
Availability: No items available.
|
|
2154.
|
PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in chronic lymphocytic leukaemia. [electronic resource] by
- Herriott, Ashleigh
- Tudhope, Susan J
- Junge, Gesa
- Rodrigues, Natalie
- Patterson, Miranda J
- Woodhouse, Laura
- Lunec, John
- Hunter, Jill E
- Mulligan, Evan A
- Cole, Michael
- Allinson, Lisa M
- Wallis, Jonathan P
- Marshall, Scott
- Wang, Evelyn
- Curtin, Nicola J
- Willmore, Elaine
Producer: 20161007
In:
Oncotarget vol. 6
Availability: No items available.
|
|
2155.
|
|
|
2156.
|
Cinnamaldehyde accelerates wound healing by promoting angiogenesis via up-regulation of PI3K and MAPK signaling pathways. [electronic resource] by
- Yuan, Xing
- Han, Lin
- Fu, Peng
- Zeng, Huawu
- Lv, Chao
- Chang, Wanlin
- Runyon, R Scott
- Ishii, Momoko
- Han, Liwen
- Liu, Kechun
- Fan, Taiping
- Zhang, Weidong
- Liu, Runhui
Producer: 20190328
In:
Laboratory investigation; a journal of technical methods and pathology vol. 98
Availability: No items available.
|
|
2157.
|
|
|
2158.
|
|
|
2159.
|
Tumor growth inhibition by olaparib in BRCA2 germline-mutated patient-derived ovarian cancer tissue xenografts. [electronic resource] by
- Kortmann, Ursula
- McAlpine, Jessica N
- Xue, Hui
- Guan, Jun
- Ha, Gavin
- Tully, Sophie
- Shafait, Sharaz
- Lau, Alan
- Cranston, Aaron N
- O'Connor, Mark J
- Huntsman, David G
- Wang, Yuzhuo
- Gilks, C Blake
Producer: 20110815
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 17
Availability: No items available.
|
|
2160.
|
|